BioSig Technologies to Present at the 31st Annual ROTH Conference
March 07, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 07, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Announces Expansion of Engineering Team
February 26, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Announces Successful First-In-Human Use of PURE EP System
February 20, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Appoints John Kowalski to Lead Commercialization of PURE EP
February 05, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
December 06, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies
November 27, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...